Member access

4-Traders Homepage  >  Shares  >  Amex  >  Protalix BioTherapeutics Inc.    PLX   US74365A1016

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Amex
04/10/2014 04/11/2014 04/14/2014 04/15/2014 04/16/2014 Date
4.49(c) 4.39(c) 4.25(c) 4.31(c) 4.17 Last
74 530 166 403 98 679 125 911 144 317 Volume
-4.26% -2.23% -3.19% +1.41% -3.25% Change
More quotes
Company
Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system. It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease. Its... 
Sector
Biotechnology
Calendar
-
Surperformance© rating of Protalix BioTherapeutics I
Trading Rating : Investor Rating :
More about the company
Chart PROTALIX BIOTHERAPEUTICS I
Duration : Period :
Protalix BioTherapeutics I Technical Analysis Chart | PLX | US74365A1016 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 15,8 M
EBIT 2013 -19,9 M
Net income 2013 -19,0 M
Debt 2013 -
Yield 2013 -
Sales 2014 46,4 M
EBIT 2014 -5,80 M
Net income 2014 -1,21 M
Debt 2014 -
Yield 2014 -
PER 2013 -
PER 2014
Capi. / Sales 2013 25,3x
Capi. / Sales 2014 8,56x
Capitalization 398 M
More Financials
Latest news on PROTALIX BIOTHERAPEUTICS I
04/04 PROTALIX BIOTHERAPEUTICS : Apple Orthodontix Frisco TX Orthodontist David Blackb..
02/12 PROTALIX BIOTHERAPEUTICS INC. : PROTALIX BIOTHERAPEUTICS, INC. FILES (8-K) Discl..
02/12 PROTALIX BIOTHERAPEUTICS INC. : Protalix BioTherapeutics Announces Oral GCD Data..
02/06 PROTALIX BIOTHERAPEUTICS INC. : Protalix BioTherapeutics' Technology Transfer Ag..
01/23 Protalix Announces Successful Manufacturing Facility Evaluation by Health Can..
01/13 PROTALIX BIOTHERAPEUTICS INC. : PROTALIX BIOTHERAPEUTICS, INC. FILES (8-K) Discl..
01/13 PROTALIX BIOTHERAPEUTICS INC. : Protalix BioTherapeutics Provides Full-Year 2014..
01/07 PROTALIX BIOTHERAPEUTICS INC. : Protalix BioTherapeutics to Present at the 32nd ..
2013 PROTALIX BIOTHERAPEUTICS INC. : Protalix BioTherapeutics to Present at Oppenheim..
2013DJFIDELITY MANAGEMENT & RESEARCH CO. 3 : -2-
2013DJFIDELITY MANAGEMENT & RESEARCH CO. 3 : Largest Eliminations
2013 PROTALIX BIOTHERAPEUTICS INC. : Protalix BioTherapeutics to Present at Upcoming ..
More news
Comments 
Advertisement
Income Statement Evolution
Protalix BioTherapeutics I : Income Statement Evolution
More Financials
EPS Revisions
Protalix BioTherapeutics I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF